What is the current price of Ascendis Pharma A/S Ordinary Share (ASND) stock?

Ascendis Pharma A/S Ordinary Share (ASND) stock is trading at US$240.80, +1.72% from the previous close of US$236.72.

What is the market cap for Ascendis Pharma A/S Ordinary Share (ASND) stock?

The market cap for Ascendis Pharma A/S Ordinary Share (ASND) stock is approximately US$16.61B.

What is the P/E ratio for Ascendis Pharma A/S Ordinary Share (ASND) stock?

The price-to-earnings ratio for Ascendis Pharma A/S Ordinary Share (ASND) is 20.23, based on the latest reported earnings.

What is the 52-week high for Ascendis Pharma A/S Ordinary Share (ASND) stock?

The 52-week high for Ascendis Pharma A/S Ordinary Share (ASND) stock is US$282.15.

What is the 52-week low for Ascendis Pharma A/S Ordinary Share (ASND) stock?

The 52-week low for Ascendis Pharma A/S Ordinary Share (ASND) stock is US$186.05.

Does Ascendis Pharma A/S Ordinary Share (ASND) pay dividends?

Ascendis Pharma A/S Ordinary Share (ASND) does not currently pay a dividend.

Trade ASND stock anytime, 24x5 in Singapore

$0* Commission

$0 Platform fee

Regulated by

Monetary Authority of Singapore (MAS)

Trusted by

400,000+ users

ASNDUS

Ascendis Pharma A/S Ordinary Share (ASND) Stock Price

Overview

Ascendis Pharma A/S Ordinary Share (ASND) is trading at US$240.80, up 1.72% today as of Sep 21, 10:48 EDT. The company has a market capitalisation of US$16.61B. Over the past 52 weeks, ASND has traded between US$186.05 and US$282.15. On Syfe you can trade ASND with $0 commission and add it to your watchlist.

Key Statistics

Previous close	US$236.72
Market cap	US$16.61B
P/E ratio	20.23
52-week range	US$186.05 – US$282.15
Volume	1.56M
Exchange	US

Add to Watchlist

Set Price Alert

About

ASNDUS

Ascendis Pharma A/S Ordinary Share

US Stocks

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Year: 2026